Because ●NO and/or its metabolites are cytotoxic to tumor cells [6], our laboratory has been involved in identifying tumor-specific cytotoxic nitric oxide donors that can be utilized for the reversal of drug resistance caused by the overexpression of ABC transporters in tumor cells [5,7,8]. The gene discussed is ABCG2; the disease is neoplasm.